Physician profile
Eric J Sleeper
NPI 1538194592
$1,804.00
in general payments reported to CMS, 2019-2025
22 companies · $477 in 2025
The $477 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $56.91 · 2022: $18.64 · 2023: $306 · 2024: $785 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $169.80 | 2023-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $152.66 | 2019-2025 | |
| Sobi, INC | $143.63 | 2019-2024 | |
| Glaxosmithkline, LLC. | $137.98 | 2019-2025 | Bexsero, Rotarix |
| Kaleo, INC. | $136.20 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $132.73 | 2023-2024 | |
| Corium, LLC | $128.34 | 2024-2025 | Azstarys |
| Seqirus USA INC | $97.14 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Organon LLC | $86.68 | 2024-2025 | Nexplanon |
| Collegium Pharmaceutical, INC. | $85.91 | 2025 | Jornay Pm |
| Baxter Healthcare | $75.48 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $72.16 | 2019-2025 | Gardasil 9, Enflonsia, Gardasil |
| Sanofi-Aventis U.S. LLC | $67.60 | 2024-2025 | |
| Avion Pharmaceuticals | $52.83 | 2019-2023 | Methylphenidate Hydrochloride |
| Astrazeneca Pharmaceuticals Lp | $45.92 | 2024 | Flumist Quadrivalent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $44.59 | 2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $38.13 | 2020-2024 | Relexxii |
| Ars Pharmaceuticals Operations, INC. | $36.55 | 2025 | Neffy |
| Cranial Technologies, INC | $33.09 | 2024-2025 | Doc Band |
| Tempus Ai, INC | $29.75 | 2024 | |
| Verrica Pharmaceuticals INC. | $24.39 | 2025 | Ycanth |
| Phadia US INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sleeper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.